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Abstract
Acetyl-CoA synthetase (ACS) is a member of a large superfamily of enzymes that display diverse substrate
specificities, with a common mechanism of catalyzing the formation of a thioester bond between Coenzyme
A and a carboxylic acid, while hydrolyzing ATP to AMP and pyrophosphate. As an activated form of acetate,
acetyl-CoA is a key metabolic intermediate that links many metabolic processes, including the TCA cycle,
amino acid metabolism, fatty acid metabolism and biosynthetic processes that generate many polyketides and
some terpenes. We explored the structural basis of the specificity of ACS for only activating acetate, whereas
other members of this superfamily utilize a broad range of other carboxylate substrates. By computationally
modeling the structure of the Arabidopsis ACS and the Pseudomonas chlororaphis isobutyryl-CoA synthetase
using the experimentally determined tertiary structures of homologous ACS enzymes as templates, we
identified residues that potentially comprise the carboxylate binding pocket. These predictions were
systematically tested by mutagenesis of four specific residues. The resulting rationally redesigned carboxylate
binding pocket modified the size and chemo-physical properties of the carboxylate binding pocket. This
redesign successfully switched a highly specific enzyme from using only acetate, to be equally specific for using
longer linear (up to hexanoate) or branched chain (methylvalerate) carboxylate substrates. The significance of
this achievement is that it sets a precedent for understanding the structure–function relationship of an
enzyme without the need for an experimentally determined tertiary structure of that target enzyme, and
rationally generates new biocatalysts for metabolic engineering of a broad range of metabolic processes.
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ABSTRACT: Acetyl-CoA synthetase (ACS) is a member of a
large superfamily of enzymes that display diverse substrate
speciﬁcities, with a common mechanism of catalyzing the
formation of a thioester bond between Coenzyme A and a
carboxylic acid, while hydrolyzing ATP to AMP and
pyrophosphate. As an activated form of acetate, acetyl-CoA
is a key metabolic intermediate that links many metabolic
processes, including the TCA cycle, amino acid metabolism,
fatty acid metabolism and biosynthetic processes that generate
many polyketides and some terpenes. We explored the
structural basis of the speciﬁcity of ACS for only activating acetate, whereas other members of this superfamily utilize a
broad range of other carboxylate substrates. By computationally modeling the structure of the Arabidopsis ACS and the
Pseudomonas chlororaphis isobutyryl-CoA synthetase using the experimentally determined tertiary structures of homologous
ACS enzymes as templates, we identiﬁed residues that potentially comprise the carboxylate binding pocket. These predictions
were systematically tested by mutagenesis of four speciﬁc residues. The resulting rationally redesigned carboxylate binding
pocket modiﬁed the size and chemo-physical properties of the carboxylate binding pocket. This redesign successfully switched a
highly speciﬁc enzyme from using only acetate, to be equally speciﬁc for using longer linear (up to hexanoate) or branched
chain (methylvalerate) carboxylate substrates. The signiﬁcance of this achievement is that it sets a precedent for understanding
the structure−function relationship of an enzyme without the need for an experimentally determined tertiary structure of that
target enzyme, and rationally generates new biocatalysts for metabolic engineering of a broad range of metabolic processes.
KEYWORDS: acetyl-CoA synthetase, targeted mutagenesis, enzyme engineering, substrate speciﬁcity, homologous enzymes,
Arabidopsis
The promise of synthetic biology is based on the premisethat the systematic application of engineering principles
to redesign individual molecular entities can outcompete
natural evolutionary-based optimized design of complex
biological processes. Furthermore, these individual genetically
encoded redesigned entities can be fabricated into assemblages
of novel systems (chassis), which do not already exist in the
natural world.1,2 Enzyme catalysts that provide speciﬁcity and
enhanced rates of chemical conversions are key biological
entities that are targets of such human-driven optimization. A
limiting factor in such optimization redesigns is the fact that
enzymatic functionality is based on tertiary structural design
principles that cannot a priori be deduced from primary
structural data, which are the most readily available data sets
concerning structures of enzymes. This study illustrates a
research path for redesigning a speciﬁc enzyme whose tertiary
structure is unknown, but could be computationally modeled
based on tertiary structures of functionally related enzymes.3,4
The systematic targeted engineering of an AMP-generating
acetyl-CoA synthetase from Arabidopsis thaliana (atACS) led
to the redesign of this enzyme to generate new synthetic
enzymes that display distinct catalytic capabilities not present
in any of the enzymes that served as templates for the redesign.
The atACS enzyme is a member of the AMP-forming acyl-
CoA synthetase family, which is part of the adenylate forming
superfamily of enzymes.5−7 The initial half reaction catalyzed
by this superfamily of enzymes activates a carboxylate substrate
by converting the hydroxyl leaving group of the substrate to an
adenosine monophosphate (adenylate intermediate) using the
hydrolysis of PPi to drive the reaction in the forward
direction7−9 (Figure 1). In the second half reaction, the
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adenylate intermediate reacts with the thiol group of the
phosphopantothenate group of Coenzyme A, generating an
acyl-CoA product, which can be considered as the “activated”
form of the carboxylate substrate.7,10 Diﬀerent acyl-CoA
synthetases in this family act upon diﬀerent carboxylate
substrates, and these include for example, acetate, propionate,
malonate and chloro-benzoate,4,11−15 which vary in the nature
of the alkyl group of the carboxylate substrate.
Thioester bonds, as occurs in acyl-CoA, are crucial to a large
number of anabolic and catabolic processes. These include
fatty acid and polyketide metabolism, assembly of complex
lipids, amino acid metabolism, assembly of mevalonate for the
biosynthesis of isoprenoids, and porphyrin biosynthesis.10,16
Chemically the formation of the thioester bond facilitates the
subsequent reactions of the acyl moiety because of the high
energy content of the bond, and because the thiol group is a
better leaving group than the hydroxyl group of the initial
carboxylate substrate for the nucleophilic reactions, that lead to
the formation of diﬀerent carbonyl-containing products (e.g.,
esters, amides and ketones). Indeed, because of the high
energy content of the thioester bond, and its chemical
ﬂexibility, it has been theorized that it could have been a
precursor to life, preceding the role of ATP as the common
energy carrier in a so-called “thioester world”.17
The most prevalent thioester-containing intermediate of
metabolism is acetyl-CoA, and biological systems utilize
multiple enzymatic mechanisms to generate this central
metabolite. Most prevalent of these reactions is likely the
oxidative decarboxylation of pyruvate, catalyzed by the
pyruvate dehydrogenase complex,18 and the retro-Claisen
cleavage of citrate, catalyzed by ATP-citrate lyase.19 However,
ACS is part of a large family of enzymes that is widely
prevalent in biological systems, and in some cases, such as in
plants, the physiological relevance of this enzyme to
Figure 1. Enzymatic mechanism of AMP-forming acetyl-CoA synthetase. The reaction occurs in two steps, where an acetyl-adenylate intermediate
is formed in the ﬁrst half-reaction. This intermediate then reacts with Coenzyme A to form acetyl-CoA and release AMP.
Table 1. Sequence Identity (%) and RMSD (Å) Values of All Atom Structural Alignment of 3D Structures of atACS and
Several Acyl-CoA Synthetasesa
1PG4c 1RY2c pcICSb atACSb 3NYRc 1MD9c mtACSb atMCSb sePCSb
% Å % Å % Å % Å % Å % Å % Å % Å % Å
1PG4c 45.5 10.5 30 13.7 53.9 1.8 23.4 6.7 19.9 13.1 48 1.5 22.9 8.6 37 2.4
1RY2c 30.5 8.8 45.9 10.5 21 16.9 18 6.6 43 10.6 21.8 11.7 37.3 10.8
pcICSb 29.4 14 24.5 14.7 19.0 10.4 31.4 14 21.6 12.6 26.0 13.5
atACSb 22 8.3 21 13.7 46.4 3.7 22 6.8 35.8 3.2
3NYRc 27.6 12.5 23.3 6.5 39.8 4.6 21 9.2
1MD9c 22 13.1 23.9 11.8 21.5 12.4
mtACSb 22.7 11.6 37.3 2.8
atMCSb 18 10.2
sePCSb
a1PG4: Salmonella enterica acetyl-CoA synthetase; 1RY2: Saccharomyces cerevisiae acetyl-CoA synthetase 1; pcICS: Pseudomonas chlororaphis
isobutyryl-CoA synthetase; atACS: Arabidopsis thaliana acetyl-CoA synthetase; 3NYR: Streptomyces coelicolor malonyl-CoA ligase; 1MD9: Bacillus
subtilis adenylation domain of NRPS to activate 2,3-dihydroxybenzoate; mtACS: Methanobacter thermoautotrophicus acetyl-CoA synthetase;
atMCS: Arabidopsis thaliana malonyl-CoA synthetase; sePCS: Salmonella enterica propionyl-CoA synthetase. bIndicates proteins whose tertiary
structures were computationally generated. cIndicates proteins whose tertiary structures were experimentally determined.
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metabolism is not clear.18,20−23 Due to this potential metabolic
redundancy, engineering ACS to utilize diﬀerent carboxylate
substrates has considerable potential in impacting the end-
products of metabolism, particularly in plant systems. Acetyl-
CoA is a key precursor of fatty acid biosynthesis and many
polyketide biosynthetic processes, and in both complex
processes it is the precursor of the malonyl-CoA substrate
that is used to elongate the fatty acids or polyketides (e.g.,
chalcone synthase).24−26 Hence, engineering ACS to utilize
novel carboxylate substrates would generate alternative acyl-
CoA substrates for fatty acid or polyketide biosynthesis would
provide the means to explore the enzymological ﬂexibilities of
these biosynthetic machineries and build a technology platform
to produce a diversity of chemical products with wide ranging
applications.27 As a prerequisite to such redesign of biological
chassis, in this study we have been successful in not only
broadening the substrate speciﬁcity of a eukaryotic ACS, but
shifting its substrate speciﬁcity, using a systematic targeted
mutagenesis strategy.
■ RESULTS AND DISCUSSION
Identiﬁcation of the Residues Forming the Putative
Carboxylate Binding Pocket of atACS. Alignment of
sequences of multiple acyl-CoA synthetases, which utilize
diﬀerent carboxylate substrates, reveal that atACS shares
higher sequence identity (>40%) with other acyl-CoA
synthetases that utilize acetate as the preferred substrate,
rather than those that utilize propionate, isobutyrate or
malonate (Table 1). This conservation in sequence is focused
in ten motifs (A1 to A10) (Figure 2), three of which (motifs
A3, A4 and A5) have been associated with (a) the carboxylate
substrate binding pocket of acyl-CoA synthetases; (b) the
amino acid binding pocket of nonribosomal peptide synthases;
and (c) in interacting with the pyrophosphate product of these
enzymes.7,10,28 We explored the basis for the high substrate
speciﬁcity of atACS for acetate, by comparing and contrasting
the structure of this enzyme with that of the Pseudomonas
chlororaphis isobutyryl-CoA synthetase (pcICS), which is
equally speciﬁc, but for isobutyrate. Higher order structural
insights of atACS and pcICS were obtained by using 3D
structural models generated with I-TASSER,29−31 using as a
guide the experimentally determined structures of the acetate-
utilizing homologous ACS from Salmonella enterica (PDB:
1PG4)32 and Saccharomyces cerevisiae (PDB: 1RY2).33
Despite the fact that atACS and pcICS diﬀer in primary
structure (sharing only 30% sequence identity), both computa-
tionally generated 3D models of atACS and pcICS share a high
degree of tertiary structural alignment with each other and with
both S. enterica ACS and S. cerevisiae ACS. The 3D structural
alignment of atACS and pcICS structures has an all-atom root
mean square deviation (RMSD) of 14 Å for 3159 atoms; a
numerical evaluation of the structural alignment between two
tertiary structures. Comparison of the computationally
generated structures of atACS and pcICS with the
experimentally determined structures of S. enterica ACS
(1PG4) and S. cerevisiae ACS (1RY2) indicates a higher
Figure 2. Multiple sequence alignment of the amino acid sequences of acyl-CoA synthetases that utilize acetate (ACS), propionate (PCS),
isobutyrate (ICS), malonate (MCS or MCL) and 2,3-dihyroxybenzoate (DHBe) as the preferred substrate. Alignment was performed using Clustal
Omega. Asterisks indicate the residues proposed to be forming the carboxylate binding pocket. White letters on a black background indicate
identity, white letters on a gray background indicate similarity, and black letters on a white background indicate no conservation. Ten conserved
motifs of the AMP-forming family of acyl-CoA synthetases are indicated (A1-A10). UniProt/GenBank Accession numbers are S. enterica ACS
(A0A0F7JF17), E. coli ACS (P27550), A. thaliana ACS (B9DGD6), M. thermoautotrophicus ACS (DQ274062.1), S. cerevisiae ACS1 (Q01574),
S. cerevisiae ACS2 (P52910), S. enterica PCS (A0A0F7J6L9), E. coli PCS (A0A222QH41), P. chlororaphis ICS (WP_069076265), A. thaliana MCS
(Q8H151), S. coelicolor MCL (Q9L0A2) and B. subtilis DHBe (P40871).
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degree of 3D structural alignment among the enzymes that
share the common substrate, acetate. Speciﬁcally, the all-atom
RMSD comparison between atACS and S. enterica ACS or
S. cerevisiae ACS is 1.8 and 10.5 Å, respectively, whereas the
homologous comparisons between pcICS and S. enterica ACS
or S. cerevisiae ACS is 13.7 and 8.8 Å, respectively (Table 1 and
Figure 3A,B). Therefore, the atACS model has smaller RMSD
values when compared to enzymes that act on smaller
carboxylate substrates (e.g., acetate, malonate and propionate)
as compared to enzymes that act on larger carboxylate
substrates (e.g., isobutyrate or benzoate) (Table 1). These
insights are consistent with prior studies of this class of
enzymes, which indicate that substrate speciﬁcity cannot be
assigned solely based upon primary sequence similarity but can
more accurately be deduced based upon higher order structural
templates.34 Therefore, these 3D structural comparisons
provide more valuable and accurate insights into the design
principles of the substrate binding pocket that can be
experimentally validated.
These computational higher structural order comparisons
identiﬁed four residues that may comprise the carboxylate
binding pocket of atACS (i.e., residues Ile323, Thr324, Val399, and
Trp427), and of pcICS (i.e., residues Ala278, Tyr279, Ala313, and
Gly338) (Figure 3C,D). Conﬁdence that these identiﬁed
residues are important for enzymatic function is further
enhanced by the fact that the former set are conserved in all
acyl-CoA synthetases that utilize acetate as the preferred
carboxylate substrate (Figure 2). Furthermore, these residues
were previously identiﬁed by the comparison of ACS from
Methanobacter thermautotrophicus and Archaeoglobus fulgi-
dus,35,36 and they also coincide with the 15 residues previously
predicted by the in silico analysis of this superfamily of
enzymes.34,37
The accuracy of our predictions were evaluated by singularly
and in combination mutating the atACS residues (i.e., Ile323,
Thr324, Val399, and Trp427) to the corresponding residues that
comprise the binding pocket of pcICS (Figure 2). The
expectation is that these mutations would aﬀect catalysis and/
or alter the carboxylate substrate speciﬁcity of the atACS
enzyme. The kinetic parameters (Vmax, Km, and kcat) of the
resulting mutant proteins were determined with a range of
diﬀerent carboxylate substrates, including a series of straight
chain carboxylates (acetate to octanoate) and branched chain
carboxylates (isobutyrate, 3-methylvalerate, 4-methylvalerate,
and 4-methylhexanoate), and these data were compared to the
parallel data generated with the wild-type atACS.
Mutations That Identify an Important Residue for
Catalysis. The atACS enzyme follows traditional Michaelis−
Menten kinetics, with a strong preference for acetate as the
carboxylate substrate. Speciﬁcally, the catalytic eﬃciency (kcat/
Km) is approximately 55-fold higher with acetate than
propionate, and there is no detectable activity with longer
chain carboxylates (Table 2). The singular replacement of the
Thr324 residue with the Tyr residue that occurs at this position
in the pcICS structure inactivates atACS with all tested
substrates. Furthermore, each multisite mutant that contained
Figure 3. (A) Comparisons of the 3D structural homology models of atACS (cyan ribbon diagram) and pcICS (green ribbon diagram) predicted
using I-TASSER, and the experimentally determined structures of scACS (1RY2) (pink ribbon diagram) and seACS (1PG4) (yellow ribbon
diagram). These structures were aligned using PyMOL. (B) Comparisons of the 3D structural homology models of atACS (purple ribbon diagram)
and pcICS (green ribbon diagram) computationally predicted using I-TASSER and aligned using PyMOL. (C) Predicted position of the residues
that constitute the putative carboxylate binding pocket of atACS (purple), ecACS (blue), ecPCS (pink), and pcICS (green). These alignments were
guided with the experimentally determined tertiary structure of the seACS (beige). Numbers represent the position of the homologous residue in
the atACS protein. (D) Putative binding pocket residues of atACS from the homology structure predicted using I-TASSER, aligned with the
derived structures of Coenzyme A, AMP and the acetyl group from the experimentally determined structure of these substrates in 1RY2 and 1PG4.
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Table 2. Kinetic Parameters of atACS Variantsa
atACS variant carboxylate substrate Km (mM) kcat (s
−1) kcat/Km (s
−1 mM−1)
wild-type acetate 0.27 ± 0.01 2.41 ± 0.03 8.9 ± 0.5
propionate 4.0 ± 1.2 0.66 ± 0.07 0.16 ± 0.05
Val399Ala acetate 3.1 ± 0.2 3.04 ± 0.05 0.99 ± 0.07
propionate 3.1 ± 0.4 2.65 ± 0.07 0.85 ± 0.10
Trp427Gly acetate 10.8 ± 1.8 14.3 ± 0.9 1.32 ± 0.24
propionate 37.5 ± 5.0 6.2 ± 0.5 0.16 ± 0.03
butyrate 2.9 ± 0.6 9.4 ± 0.5 3.3 ± 0.7
valerate 6.5 ± 0.7 13.8 ± 0.4 2.13 ± 0.25
hexanoate 12.6 ± 1.4 13.0 ± 0.5 1.03 ± 0.12
heptanoate 10.0 ± 1.8 11.0 ± 0.6 1.10 ± 0.20
octanoate 48 ± 12 5.8 ± 0.8 0.12 ± 0.03
Val399Ala, Trp427Gly acetate 44 ± 6 5.07 ± 0.31 0.11 ± 0.02
propionate 31 ± 5 12.94 ± 1.07 0.41 ± 0.07
butyrate 1.5 ± 0.1 14.87 ± 0.57 9.9 ± 1.0
valerate 4.0 ± 0.6 12.25 ± 0.47 3.1 ± 0.5
hexanoate 7.3 ± 0.9 9.20 ± 0.31 1.3 ± 0.2
heptanoate 5.8 ± 0.9 9.12 ± 0.43 1.6 ± 0.2
octanoate 6.3 ± 2 3.04 ± 0.30 0.48 ± 0.16
Thr324Val acetate 0.042 ± 0.008 0.99 ± 0.02 24 ± 5
propionate 0.62 ± 0.23 1.1 ± 0.1 1.8 ± 0.8
isobutyrate 2.1 ± 0.8 0.33 ± 0.05 0.15 ± 0.08
3-methylvalerate 125 ± 416 3.9 ± 1 0.03 ± 0.2
Thr324Gly acetate 0.18 ± 0.04 1.91 ± 0.08 10.4 ± 2.9
propionate 3.2 ± 1.1 1.78 ± 0.26 0.56 ± 0.28
butyrate 0.19 ± 0.09 0.13 ± 0.01 0.68 ± 0.34
isobutyrate 0.15 ± 0.30 0.23 ± 0.08 1.6 ± 2.4
3-methylvalerate 0.04 ± 0.06 0.077 ± 0.009 1.9 ± 2.9
4-methylvalerate 0.07 ± 0.05 0.17 ± 0.01 2.4 ± 2.1
wild-type* acetate 0.12 ± 0.04 5.7 ± 0.3 48 ± 7
Thr324Gly, Val399Ala, Trp427Gly* acetate 7.8 ± 17 0.6 ± 0.7 0.07 ± 0.2
propionate 98 ± 45 3.3 ± 0.9 0.03 ± 0.02
butyrate 20 ± 2 6.7 ± 0.2 0.33 ± 0.04
valerate 0.4 ± 0.1 8.8 ± 0.5 22 ± 6
hexanoate 0.13 ± 0.05 5.7 ± 0.4 43 ± 18
heptanoate 0.71 ± 0.45 11.0 ± 1.9 15 ± 9.8
octanoate 2.1 ± 0.7 5.2 ± 0.6 2.4 ± 0.9
isobutyrate 219 ± 69 4.0 ± 0.9 0.018 ± 0.007
3-methylvalerate 2.7 ± 0.6 7.7 ± 0.6 2.9 ± 0.6
4-methylvalerate 0.22 ± 0.07 6.6 ± 0.4 29 ± 10
4-methylhexanoate 0.25 ± 0.05 5.9 ± 0.2 2 ± 4
Ile323Ala, Val399Ala, Trp427Gly* propionate 98 ± 42 3.3 ± 0.8 0.03 ± 0.02
valerate 2.3 ± 0.7 2.7 ± 0.3 1.20 ± 0.38
hexanoate 0.58 ± 0.05 2.67 ± 0.06 4.62 ± 0.40
heptanoate 1.05 ± 0.13 2.22 ± 0.08 2.11 ± 0.27
octanoate 4.1 ± 2.4 6.1 ± 1.6 1.47 ± 0.95
isobutyrate 110 ± 42 3.2 ± 0.8 0.03 ± 0.01
3-methylvalerate 1.5 ± 0.4 1.9 ± 0.2 1.22 ± 0.37
4-methylvalerate 4.3 ± 0.5 6.7 ± 0.3 1.57 ± 0.19
4-methylhexanoate 1.0 ± 0.3 1.5 ± 0.1 1.6 ± 0.51
Ile323Ala, Val399Gly, Trp427Gly* butyrate 4.5 ± 0.9 3.8 ± 0.4 0.9 ± 0.2
valerate 2.1 ± 1.8 2.2 ± 0.7 1.0 ± 1.0
hexanoate 7.8 ± 1.0 4.8 ± 0.4 0.62 ± 0.09
heptanoate 5.0 ± 1.3 5.4 ± 0.7 1.1 ± 0.3
octanoate 2.4 ± 0.7 4.5 ± 0.5 1.9 ± 0.5
3-methylvalerate 3.01 ± 0.4 2.5 ± 0.1 0.8 ± 0.1
4-methylvalerate 1.2 ± 0.4 3.0 ± 0.3 2.4 ± 0.8
Thr324Ser, Val399Ala, Trp427Gly* butyrate 16 ± 5 19 ± 4 1.2 ± 0.5
valerate 1.5 ± 0.5 7.2 ± 0.9 4.9 ± 1.8
4-methylvalerate 1.2 ± 0.3 8.2 ± 0.6 6.7 ± 1.6
Trp427Ala* acetate 1.9 ± 0.4 11.0 ± 0.8 6.0 ± 1.2
propionate 23 ± 11 21 ± 7 0.9 ± 0.5
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this Thr324Tyr mutation (i.e., the double mutant Ile323Ala,
Thr324Tyr and the quadruple mutant Ile323Ala, Thr324Tyr,
Val399Ala, Trp427Gly) also fails to exhibit enzymatic activity
with any of the tested carboxylate substrates (Table 2). The
CD spectra of these mutants indicate near normal folding of
the mutant proteins (Figure 4). However, homology modeling
of the Thr324Tyr mutant protein revealed a change in the
surface topology of the predicted substrate binding pocket
resulting in a decreased volume for binding of the carboxylate
substrate (Figure 5). This is consistent therefore with steric
hindrance hampering the ability of the carboxylate substrates
to access the catalytic site and thereby inactivating the enzyme.
Mutations That Switch Substrate Speciﬁcity to
Longer, Linear Chain Carboxylate Substrates. Two single
site mutants, Trp427Gly and Val399Ala, resulted in altered
substrate speciﬁcity of atACS. The former mutation causes the
most dramatic alteration, switching the substrate preference
from acetate to longer, straight-chain carboxylate substrates.
Namely, this mutant enzyme is able to utilize “new”
carboxylate substrates that range between 3- to 8-carbons in
length (Table 2). Furthermore, this switch is accompanied by a
6.5-fold decrease in catalytic eﬃciency (kcat/Km) with acetate,
the native substrate of the wild-type enzyme (Figure 6A).
The other single-site mutant that aﬀected catalytic
capabilities of atACS is the Val399Ala switch, which broadened
the substrate speciﬁcity of the enzyme so that it could equally
utilize both acetate and propionate. However, unlike the
Trp427Gly mutant, the Val399Ala mutant enzyme could not
utilize longer chain carboxylate substrates of 4−8 carbon atoms
(Table 2).
On the basis of the fact that these two single site mutations
at Val399 and Trp427 individually generate somewhat distinct
changes in catalytic activity of atACS, we evaluated the eﬀect of
combining the two mutations in the double mutant, Val399Ala,
Trp427Gly. This double mutant further enhanced the switch in
substrate speciﬁcity that was observed with the Trp427Gly
single mutant (Figure 6A). Speciﬁcally, as compared to the
wild-type enzyme, the Val399Ala, Trp427Gly double mutant
shows an 80-fold decrease in catalytic eﬃciency with the
acetate-substrate, and a concomitant increase in catalytic
eﬃciency with the longer, straight chain carboxylate substrates
(i.e., propionate to octanoate). With propionate as the
substrate, this double mutant enzyme shows a 2.5-fold increase
in catalytic eﬃciency as compared to either the wild-type
enzyme or the Trp427Gly single mutant (Figure 6A). The
catalytic eﬃciency with butyrate, the best substrate for this
mutant enzyme, matched the catalytic eﬃciency expressed by
the wild-type enzyme with acetate. With these “new” longer
chain-length substrates, the double mutant enzyme displayed a
lower Km value (ranging from 1.5 to 7.5-fold lower values) than
the Trp427Gly single mutant (Table 2). Analysis of the
structural homology models indicate that both the Trp427Gly
and Val399Ala single mutations enlarge the carboxylate binding
pocket signiﬁcantly, and further enlargement is apparent in the
Val399Ala, Trp427Gly double mutant. Thus, these models are
consistent with the ability of these variant enzymes to use the
larger substrates, and in general it is likely that steric hindrance
is a major factor in narrowing the substrate speciﬁcity for the
native atACS enzyme (Figure 5).
Mutations That Switch Substrate Speciﬁcity to
Branched Chain Carboxylate Substrates. The Thr324
residue of atACS, which we showed to be critical for catalytic
competence because its replacement with the equivalent
residue that occurs in pcICS (i.e., Tyr) resulted in an inactive
enzyme, was subsequently replaced with residues that have
smaller side chains. These mutations were systematically
implemented to explore whether maintaining either the
hydroxyl-group functionality (i.e., a serine switch) or the
branched alkyl chain functionality (i.e., a valine switch) or
completely eliminating the side chain (i.e., a glycine switch) of
the existing Thr residue is important for catalysis.
The Thr324Ser variant did not show any activity with acetate
or longer straight chain substrates (Table 2); however, the
Table 2. continued
atACS variant carboxylate substrate Km (mM) kcat (s
−1) kcat/Km (s
−1 mM−1)
butyrate 5.1 ± 0.7 10.8 ± 0.8 2.1 ± 0.3
Trp427Ser* acetate 8.9 ± 3.8 7.2 ± 1.8 0.81 ± 0.4
isobutyrate 1.6 ± 1.4 1.5 ± 0.5 1.0 ± 0.9
Trp427His* acetate 14 ± 11 15 ± 7 1.1 ± 0.9
Trp427Val* acetate 10 ± 2 10.6 ± 1.4 1.0 ± 0.3
propionate 38 ± 27 2.5 ± 1.5 0.06 ± 0.06
Trp427Phe* acetate 1.2 ± 0.4 11.7 ± 1.1 15.2 ± 4.7
aThe variants marked with asterisk (*) were extracted with the puriﬁcation protocol using HEPES buﬀer, while all other enzymes were puriﬁed
with Tris-HCl buﬀer (see Methods). For reasons that are currently unknown, the enzyme puriﬁed with the HEPES buﬀer displayed higher activity
than the preparations made with Tris-HCl buﬀer. All enzyme variants were assayed with all 11 carboxylate substrates listed in the Methods, but data
are only presented with the carboxylate substrates that exhibited catalytic activity.
Figure 4. Comparison of CD spectra of wild-type atACS and the
mutated variants. Measurements are an average of three scans with a
reading every 0.2 nm. Units are in molar ellipticity [θ].
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Thr324Val and Thr324Gly variants maintain the ability to utilize
acetate as a substrate, but with quantitative diﬀerences between
them (Figure 6B; Table 2). Namely, the catalytic eﬃciency of
the Thr324Val mutant is about 2-fold higher than either the
wild-type or Thr324Gly variant with acetate, and this was
primarily due to a lower Km value for this substrate. Moreover,
the Thr324Val and Thr324Gly single mutants also showed
qualitative diﬀerences in substrate speciﬁcity, gaining the
ability to utilize branched chain carboxylate substrates, such as
isobutyrate and 4-methylvalerate, a capability that is undetect-
able with the wild-type atACS (Figure 6B; Table 2).
The 3D homology models of these Thr324 single mutants
reveal the potential explanations of these eﬀects on catalytic
ability of the variant enzymes. In contrast to the Thr324Tyr
single mutant, which inactivates the enzyme due to an apparent
reduction in the size of the carboxylate binding pocket (Figure
5), the Thr324Gly single mutant is predicted to have a larger
carboxylate binding pocket as compared to the wild-type
enzyme, thus explaining the ability of this mutant to utilize the
larger, branched chain carboxylate substrates (Figure 5).
Similarly, the Thr324Val single mutant is also predicted to
have a larger carboxylate binding pocket, although smaller than
the Thr324Gly single mutant, which explains the ability of this
single mutant to utilize straight-chain substrates, up to three
carbon atoms in length (i.e., propionate) and also branched
chain substrates, albeit with lower eﬃciency as compared to
the Thr324Gly single mutant. The size of the binding pocket of
the Thr324Ser mutant is similar to the wild-type enzyme
(Figure 5), thus the inactivity of this single site mutant cannot
be explained solely based on steric interference between the
substrate and pocket-size, but instead may be attributable to
the diﬀerence in the polarity of the pocket aﬀected by the
orientation of the hydroxyl group of the Ser side chain as
compared to Thr in wild-type (Figure 5). These ﬁndings
therefore indicate that both steric eﬀects and the chemo-
physical properties (polarity versus hydrophobicity) of the
binding pocket aﬀect the carboxylate speciﬁcity of the enzyme.
On the basis of these observations, we systematically
combined the singular Thr324Gly or Thr324Ser mutations
with the double mutant, Val399Ala, Trp427Gly, to evaluate the
interrelationships among these residues to aﬀect catalytic
capabilities of atACS. The enzymatic capabilities of the
resulting Thr324Gly, Val399Ala, Trp427Gly and Thr324Ser,
Val399Ala, Trp427Gly triple mutants were compared to the
wild-type and the parental double mutant enzymes.
These triple mutants express enhanced catalytic capabilities
in utilizing longer chain linear carboxylate substrates than the
Val399Ala, Trp427Gly double mutant enzyme (Figure 6C).
Thus, whereas the double mutant can utilize butyrate with the
highest eﬃciency (Figure 6A), the Thr324Gly, Val399Ala,
Figure 5. Comparison of the carboxylate binding pocket surface computationally generated from 3D structure homology models of the wild-type
and mutants of atACS. The mutated residues are colored in tan. The change in binding pocket size and shape is highlighted with a red box. The
nitrogen and oxygen atoms of the targeted residues are shown in blue and red, respectively. The orange circle indicates the cut away opening to
reveal the inside of the carboxylate binding pocket. The chemo-physical nature of the cavity surface is color-coded as tan for hydrophobic, red for
negatively changed polarity, and blue for positively charged polarity. The binding pocket model was generated using PyMOL. The Ala399 and Gly427
residues in the double and triple mutant images are not in the view as they are situated behind the expanded carboxylate binding cavity.
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Trp427Gly triple mutant can utilize hexanoate with a catalytic
eﬃciency that is comparable to that of the wild-type enzyme
with its native acetate substrate (Figure 6C). Moreover, these
triple mutants also utilize branched chain substrates, such as 3-
methylvalerate, 4-methylvalerate and 4-methylhexanoate. The
catalytic eﬃciency of this triple mutant with branched chain
carboxylate substrates is comparable to the activity expressed
by the wild-type enzyme with acetate as the substrate.
Compared to the Val399Ala, Trp427Gly double mutant, this
additional switch in the preferred carboxylate substrate by the
triple mutants is associated with decreased Km values for the
longer chain length carboxylate substrates of more than 5-
carbon atoms, and increased Km values for the shorter chain
substrates, such as propionate, butyrate and isobutyrate (Table
2).
Thus, comparing the modeled structure of the carboxylate
binding pockets of the Val399Ala, Trp427Gly double mutant,
with the Thr324Gly, Val399Ala, Trp427Gly triple mutant
indicates that the replacement of Thr324 with a smaller side
chain residue, i.e., glycine, aﬀects both the shape and size of the
binding pocket, and its polarity (Figure 5), resulting in a shift
in substrate speciﬁcity from a 2-carbon substrate, to more than
4-carbon long, straight chain and branched substrates, which
are also less polar. These ﬁndings further strengthen the
conclusion that both steric interference and chemo-physical
properties of the binding pocket plays a role in determining the
carboxylate substrate speciﬁcity of atACS.
Even more dramatic changes in substrate speciﬁcity were
generated when the Ile323Ala mutation was combined with the
Val399Ala, Trp427Gly or Val399Gly, Trp427Gly double mutations.
Thus, Figure 6C shows that both the Ile323Ala, Val399Gly,
Trp427Gly and Ile323Ala, Val399Ala, Trp427Gly triple mutants are
inactive with acetate and only show barely detectable activity
with propionate, both of these triple mutants can utilize 4- to
8-carbon straight chain carboxylates as substrates, as well as the
branched chain carboxylates, 3-methylvalerate and 4-methyl-
valerate. Detailed examination of the kinetic properties of all
the triple mutants indicate that they prefer 4-methyl branched
chain carboxylates (i.e., 4-methylvalerate and 4-methylhex-
anoate) over the 3-methyl branched carboxylate (i.e., 3-
methylvalerate), manifested by lower Km values and higher
catalytic eﬃciencies.
The structural homology models of the triple mutants
indicate that these mutations enlarge the carboxylate binding
pocket, thus explaining the capability of these mutants to
utilize longer chain substrates (Figure 5). The triple mutant
Thr324Gly, Val399Ala, Trp427Gly which displays the largest shift
in substrate speciﬁcity (Figure 6C), shows the most nonpolar
binding pocket cavity (Figure 5), which provides the potential
explanation of why this variant is more active with the most
hydrophobic carboxylate substrates. This explanation was
further explored and conﬁrmed by computational docking
experiments that compared the binding of acetate to the wild-
type atACS and the binding of 4-methyl valerate and
hexanoate to the substrate pocket of this triple mutant
(Supporting Information Figure S2).
Because the Trp427Gly mutation has a large eﬀect on
substrate speciﬁcity and promiscuity (Table 2), we explored
the consequence of changing the Trp427 residue to all other
possible amino acids. These variants thereby evaluated how the
change in the chemo-physical property of this amino acid side
chain aﬀects substrate speciﬁcity (Table 2). Only ﬁve of the 18
additional variants were catalytically active (Val, Ala, Phe, Ser
or His), and the other 13 were inactive with all tested
carboxylates (the consequence of changing Trp427 to Gly had
already been evaluated; Figure 6). The ﬁve active single site
mutants utilize acetate as a substrate, though with lower
catalytic eﬃciency (Table 2). The mutations that incorporate
small hydrophobic side chain residues (i.e., Trp427Val or
Trp427Ala) enable the enzyme to better utilize straight chain
carboxylate substrates, of 3- and 4-carbon atoms. In addition,
the mutations that conserve the ring structure of the native
Trp427 (i.e., Trp427Phe or Trp427His) maintain enzymatic
activity with acetate. Therefore, these ﬁndings indicate that
Figure 6. Comparison of the catalytic eﬃciency (kcat/Km) of the wild-
type atACS with single and double site mutants (A, B), and triple site
mutants (C), assayed with straight- and branched-chain carboxylate
substrates. The variant enzymes in panel A were puriﬁed using the
Tris-HCl extraction buﬀer, and variants in panel C were puriﬁed using
the HEPES extraction buﬀer (see Methods). Data are the average of
triplicate determination ± standard error.
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Trp427 is an important residue in the carboxylate binding
pocket, and in addition to its aromaticity and/or polarity
associated with the indole ring, the size of the side chain has an
eﬀect on restricting the speciﬁcity of the wild-type enzyme to
acetate.
Collectively therefore, using this rational redesign strategy,
we switched an enzyme’s substrate preference from acetate to
be equally active with medium-length, straight and branched
chain carboxylate substrates. This engineered enzyme displays
catalytic activity that is comparable to the native enzyme with
its natural substrate, acetate (kcat ∼ 5 s−1). Additional
improvements can be envisioned, based on the fact that
naturally existing medium-chain acyl-CoA synthetases have
been characterized that display kcat ∼ 60 s−1 (e.g., CSAAE3
isolated from Cannabis sativa38).
Such improvements could be achieved by combining this
rational redesign with a randomized saturation mutagenesis of
the four residues that were targeted in this study. Although we
partially implemented this strategy by speciﬁcally targeting one
of the four residues (i.e., Trp427), combining this set of
mutations with a similar randomized saturation mutagenesis
strategy at the other 3 residues would generate 160 000 (=204)
variants. Assaying such a large collection of variants would
require a high-throughput assay, and the enzyme-coupled
spectroscopic assay that we used herein could be adapted for
such a high-throughput parallel assessment. Hence, combining
all possible mutant combinations at the 4 targeted residues has
the potential of uncovering synergistic combinations to
improve and alter the carboxylate substrate preference of this
class of enzymes.
Kinetics of ATP and CoA Dependence. The wild-type
atACS and selected mutants showing altered preference for the
carboxylate substrate were also characterized to evaluate the
eﬀects of these mutations on the kinetic parameters associated
with the other two substrates of the reaction, ATP and CoA
(Table 3). The assays used to determine the Km and kcat values
for these substrates were conducted with saturating concen-
trations of the most preferred carboxylate substrate for the
individual variant enzymes. These characterizations demon-
strate that the mutations that were designed to aﬀect the
speciﬁcity of the carboxylate substrate also aﬀected the
enzyme’s dependence on these two additional substrates,
although the magnitude of these changes are considerably
smaller than the changes in the kinetic parameters for the
carboxylate substrates.
The most dramatic of these changes is associated with the
kinetic parameters for ATP, with up to 10-fold decrease in Km
in mutants that enable the enzyme to better utilize longer chain
linear carboxylate substrates (e.g., Trp427Gly). In contrast, there
are relatively minor eﬀects on the kinetic parameters associated
with CoA. While in the triple-site mutant (i.e., Thr324Gly
Val399Ala Trp427Gly), which switches the carboxylate substrate
preference from acetate to the branched chain substrates, there
is increase in Km and decrease in kcat values for both ATP and
CoA. The alterations in these kinetic parameters are consistent
with the mechanism of the ACS-catalyzed reaction; namely
ATP and the carboxylate substrates ﬁrst react to form the
adenylate-intermediate, which subsequently reacts with CoA.
Thus, changing the carboxylate binding-site would be expected
to have eﬀects on ATP kinetics as these two substrates have to
come together at an active site that is juxtaposed next to each
substrate binding pocket.
■ CONCLUSION
Despite the conservation of ACS enzymes among a wide range
of evolutionary phyla, this enzyme has maintained a restricted
substrate speciﬁcity.32 For example, the plant ACS that was the
focus of this study only utilizes acetate eﬃciently as a substrate,
and propionate to a much lesser extent. In this study we
extrapolated from experimentally determined 3D structural
data of two phylogenetically distantly related ACS enzymes,
and modeled the potential carboxylate substrate binding
pockets of two enzymes that also assemble thioester bonds
but display diﬀerent speciﬁcities toward the carboxylate
substrate (acetate or isobutyrate). Rational mutagenesis
experiments guided by this modeling were successful in
initially introducing substrate promiscuity to the enzyme, and
ultimately altering its substrate speciﬁcity. We have been
particularly successful in shifting the substrate speciﬁcity of this
eukaryotic ACS away from its native substrate (acetate), to be
equally eﬃcient in utilizing novel branched chain carboxylates
that are not substrates of any of the guiding model enzymes.
Similar studies have targeted microbial ACS enzymes,35,36,39,40
which expanded the carboxylate substrates that these enzymes
can utilize, thus converting a very speciﬁc enzyme to a
promiscuous enzyme. Furthermore, apart from the four
residues targeted in this study, additional residues have been
identiﬁed (i.e., Lys627, Trp426 etc.) that appear to be important
in determining substrate selectivity and catalysis of this class of
enzymes.34,37 The variant enzymes that we have generated are
distinct in that they are not promiscuous, but they show shifted
substrate speciﬁcity, being equally eﬃcient with the new
substrates, as the wild-type enzyme is with its native substrate.
Hence, this is an exemplary study of a research path to
generate novel enzymes. Moreover, the novel acyl-CoA
synthetase enzymes that were generated herein can serve as
genetically encoded catalytic elements for bioengineering
multiple metabolic pathways and potentially producing useful
novel chemicals.27,41,42 For example, bioengineering organisms
with these novel acyl-CoA synthases may enable the
Table 3. Michaelis−Menten Kinetic Parameters of ATP and CoA for Wild-Type and Variant atACS Enzymesa
ATP CoA
enzyme carboxylate substrate Km (mM) kcat (s
−1) Km (mM) kcat (s
−1)
wild-type acetate 0.20 ± 0.03 3.56 ± 0.12 0.15 ± 0.02 3.47 ± 0.14
Val399Ala acetate 0.06 ± 0.01 2.28 ± 0.04 0.09 ± 0.02 3.20 ± 0.15
Trp427Gly butyrate 0.02 ± 0.003 6.41 ± 0.31 0.14 ± 0.05 9.36 ± 1.21
Val399Ala, Trp427Gly butyrate 0.06 ± 0.02 6.17 ± 0.66 0.09 ± 0.02 8.04 ± 0.78
wild-type* acetate 0.050 ± 0.002 16.04 ± 0.18 0.11 ± 0.03 16.03 ± 0.80
Thr324Gly, Val399Ala, Trp427Gly* hexanoate 0.26 ± 0.05 5.04 ± 0.26 0.14 ± 0.03 5.07 ± 0.20
Ile323Ala, Val399Ala, Trp427Gly* hexanoate 0.11 ± 0.03 1.60 ± 0.09 0.04 ± 0.02 1.45 ± 0.11
aThe variants marked with an asterisk (*) were puriﬁed using HEPES buﬀer, as described in the Methods.
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biosynthesis of novel fatty acids or polyketides which would
have internal branched structures, thus generating bioproducts
with distinct chemo-physical properties, and can potentially
serve as bioprivileged molecules.43
■ METHODS
Generation of atACS Variants. The atACS ORF was
cloned into the pET24b vector (Merck KGaA, Darmstadt,
Germany) between the HindIII and XhoI sites. atACS was also
subcloned into the pET30f vector at the BamHI restriction
site. pET30f vector is a modiﬁed pET30 vector (Takara,
Clontech, Mountain View, CA) encoding an N-terminal poly
histidine coding sequence, followed by a TEV cleavage site.
Mutagenesis of speciﬁc residues was performed either using
the QuikChange Lightning site-directed mutagenesis kit
(Agilent Technologies, Santa Clara, CA) via manufacturer
instructions or by recombination PCR in a two-step fashion.13
The atACS ORF cloned into the plasmid pET24b, was used as
template for QuikChange or recombination PCR. The full-
length atACS ORF PCR product containing the mutation was
puriﬁed and cloned into a pGEM T-Easy vector, and then
transformed into Top-10 competent E. coli cells. Sequence-
conﬁrmed atACS variants in pGEM T-Easy were digested with
HindIII and XhoI to release the atACS ORF and were
subcloned into the corresponding restriction sites in the
pET24b vector. Sequence-conﬁrmed pET30f and pET24b
constructs were subsequently transformed into E. coli ArcticEx-
press (DE3) cells (Agilent Technologies, Santa Clara, CA) for
protein expression.
Overexpression and Puriﬁcation of Wild-Type and
Variant atACS Proteins. Arctic Express strains harboring
atACS variants were grown overnight at 37 °C with shaking at
250 rpm, in 5−10 mL LB medium containing the antibiotics
kanamycin (50 μg/mL) and gentamycin (20 μg/mL). The
overnight culture was used to inoculate 0.5−1.0 L LB media
containing no antibiotics, and these cultures were grown at 30
°C with shaking at 250 rpm, until an OD600 of ∼0.6.
Expression was then induced by the addition of IPTG to a ﬁnal
concentration of 0.1 mM, and the culture was grown at 13 °C
with shaking at 250 rpm for 24−48 h.
Cells were harvested by centrifugation at 10 000xg for 10
min and resuspended in a buﬀer containing 0.5 M NaCl, 5 mM
imidazole, 0.1% (v/v) Triton X-100, 0.1 mg/mL phenyl
methyl sulfonyl ﬂuoride (PMSF), and 10 μL/ml Protease
Inhibitor Cocktail (Sigma-Aldrich Co., St. Louis, MO) and
disrupted by sonication on ice. Two diﬀerent buﬀer systems
were used in this cell disruption step, either 10 mM HEPES-
KOH, pH 7.5, or 20 mM Tris-HCl, pH 7.5. The resulting
extract was centrifuged at 20 000xg for 30 min, and the
supernatant was retained, ﬁltered through a 0.45 μm ﬁlter disc
(Corning Inc., Corning, NY) and applied to a column
containing 2−5 mL PerfectPro Ni-NTA agarose (5 Prime,
Inc., Gaithersburg, MD) at 4 °C. The column was washed with
increasing concentrations of imidazole, and the atACS protein
was eluted with 0.2 M imidazole. Samples were immediately
dialyzed at 4 °C into either 10 mM HEPES-KOH, pH 7.5, 10
mM KCl or 50 mM Tris-HCl pH 7.5; these two methods yield
enzyme preparations that expressed diﬀerent speciﬁc activities,
and these diﬀerences are speciﬁcally identiﬁed in the Results.
In all comparative studies of mutants, both the wild-type and
all variant enzymes were prepared identically, so as to avoid
this buﬀer-induced variation in catalytic activity, whose origins
are as of yet unknown.
Spectrophotometric atACS Activity Assay. ACS
activity was measured by coupling the carboxylate-dependent
formation of the AMP product to the oxidation of NADH
(Supporting Information Figure S1), using the enzymes
myokinase, pyruvate kinase and lactate dehydrogenase4
(Sigma-Aldrich Co., St. Louis, MO). The oxidation of
NADH was monitored by the rate of decrease in absorbance
at 340 nm. Each enzyme variant was assayed with 11 diﬀerent
carboxylate substrates that diﬀered in the alkyl chain-length
(2−8 carbons) or whether the alkyl chain was linear or
branched, and their concentrations in assays ranged between 0
and 10 mM. The speciﬁc substrates were: acetate, propionate,
butyrate, valerate, hexanoate, heptanoate, octanoate, isobuty-
rate, 3-methyl valerate, 4-methyl valerate and 4-methyl
hexanoate. Assays were performed in 96-well microtiter dishes
at 37 °C with a ﬁnal well-volume of 100 μL, and A340 of each
well was monitored with a BioTek ELx808TM Absorbance
Microplate Reader, using Gen5TM Data Analysis software
(BioTek Instruments, Winooski, VT). The standard reaction
contained 50 mM Tris-HCl pH 7.5, and 5 mM Tris(2-
carboxylethyl) phosphine hydrochloride (Thermo Fisher
Scientiﬁc Inc., Waltham, MA); 5% (v/v) ethanol; 5 mM
ATP; 6 mM MgCl2; 5 mM phospho(enol)pyruvate; 0.4 mM
NADH; 2−20 U Pyruvate Kinase/Lactate Dehydrogenase mix
(Sigma-Aldrich Co., St. Louis, MO); 10U Myokinase from
rabbit muscle or 1U Myokinase from chicken muscle (Sigma-
Aldrich Co., St. Louis, MO); and between 2.5 and 5 μg of
puriﬁed recombinant atACS protein.
Computational Experiments. The chloroplast targeting
sequence was identiﬁed in the atACS sequence using TargetP
1.147,48 (http://www.cbs.dtu.dk/services/TargetP). Amino
acid similarity and identity values of homologous proteins
were obtained using BLASTp (http://blast.ncbi.nlm.nih.gov).
Structural predictions were performed using the I-TASSER
server.28,41,44 Predicted structures and known crystal structures
were visualized and analyzed using PyMOL (The PyMOL
Molecular Graphics System, Version 1.3.0 Schrödinger, LLC).
Multiple sequence alignments were generated using Clustal
Omega.45 Docking experiments were performed using
AutoDockVina46 and results visualized using PyMOL.
Circular Dichroism. CD spectra were obtained at the Iowa
State University Protein Facility (http://www.protein.iastate.
edu/) using a J700 spectropolarimeter (JASCO Inc., Easton,
MD). Spectra were taken from 190 to 250 nm with readings
every 0.2 nm. Samples were measured in a 1 mm dichroically
neutral quartz cuvette and the average of 3−5 scans was used
for analysis. Protein samples in 50 mM Tris-HCl were diluted
into ddH2O to a ﬁnal concentration of 0.15−0.25 mg/mL for
spectra acquisition. A baseline spectrum for 5 mM Tris-HCl
was obtained in the same manner and subtracted from the
experimental protein spectra. After data collection, spectra
were converted from millidegrees to molar ellipticity ([θ],
degrees cm2 dmol−1). Spectra were analyzed using a suite of
algorithms collectively called CDPro,44 utilizing algorithms:
SELCON3, CDSSTR, and CONTIN/LL.
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Figure S1: Diagram of the assay components; Figure S2:
Docking of substrates to atACS variants (PDF)
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